Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov-Dec;19(6):647-672.
doi: 10.21873/cgp.20349.

Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation

Affiliations
Review

Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation

Ioannis Panagopoulos et al. Cancer Genomics Proteomics. 2022 Nov-Dec.

Abstract

Chromosomal translocations in cancer as well as benign neoplasias typically lead to the formation of fusion genes. Such genes may encode chimeric proteins when two protein-coding regions fuse in-frame, or they may result in deregulation of genes via promoter swapping or translocation of the gene into the vicinity of a highly active regulatory element. A less studied consequence of chromosomal translocations is the fusion of two breakpoint genes resulting in an out-of-frame chimera. The breaks then occur in one or both protein-coding regions forming a stop codon in the chimeric transcript shortly after the fusion point. Though the latter genetic events and mechanisms at first awoke little research interest, careful investigations have established them as neither rare nor inconsequential. In the present work, we review and discuss the truncation of genes in neoplastic cells resulting from chromosomal rearrangements, especially from seemingly balanced translocations.

Keywords: Chromosome aberration; gene truncation; out-of-frame fusion transcript; review; translocation.

PubMed Disclaimer

Conflict of interest statement

The Authors declare that they have no potential conflicts of interest with regards to this study.

Figures

Figure 1
Figure 1. The high mobility group AT-hook 2 (HMGA2) gene. The chromosome band location (top) and exon 5 of the gene (bottom) are shown. On exon 5, the Let7 positions are underlined. Additional microRNA target sites predicted by TargetScanHuman 7.2 are also shown. The colors indicate different classes of target sites: Purple is for 8mer, red for 7mer-m8 and blue for 7mer-A1.
Figure 2
Figure 2. The colony stimulating factor 1 (CSF1) gene. Chromosome band location (top), the four transcript variants (middle), and the last nontranslated exon 9 of the variants with accession number NM_172211.4 and NM_000757.6 (bottom) are shown. On exon 9, the G-quadruplex, the AU-rich (ARE) element, and microRNA target sites predicted by TargetScanHuman 7.2 are also shown. The colors indicate different classes of target sites: Purple is for 8mer, red for 7mer-m8 and blue for 7mer-A1.
Figure 3
Figure 3. The Fos proto-oncogene, AP-1 transcription factor subunit (FOS) gene. On the translated part of exon 4, the C-terminal region involved in FOS degradation is shown. In the untranslated part of the exon, the AU-rich (ARE) element and microRNA target sites predicted by TargetScanHuman 7.2 are shown. The colors indicate different classes of target sites: Purple is for 8mer, red for 7mer-m8 and blue for 7mer-A1. In all FOS chimeras, the FOS degradation and the untranslated region are not present.
Figure 4
Figure 4. The mitogen-activated protein kinase 8 (MAP3K8) gene. The chromosome band location (top) and exon 9 of the gene are shown (bottom). On the translated part of exon 9, the C-terminal region the kinase repression domain is shown. The underlined sequence is part of the PEST domain of MAP3K8 protein. The bold sequence is the degradation signal (degron).

References

    1. Heim S, Mitelman F. Wiley-Blackwell. 2015. Cancer cytogenetics: Chromosomal and molecular genetic abberations of tumor cells. Fourth Edition edn.
    1. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations and gene fusions in cancer. 2022. Available at: https://mitelmandatabase.isb-cgc.org/ [Last accessed on June 26, 2022]
    1. Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer. 2007;7(4):233–245. doi: 10.1038/nrc2091. - DOI - PubMed
    1. Rabbitts TH. Chromosomal translocations in human cancer. Nature. 1994;372(6502):143–149. doi: 10.1038/372143a0. - DOI - PubMed
    1. Rowley JD. The critical role of chromosome translocations in human leukemias. Annu Rev Genet. 1998;32:495–519. doi: 10.1146/annurev.genet.32.1.495. - DOI - PubMed